U.S. Transportation Stock News

NYSE:CACI
NYSE:CACIProfessional Services

CACI (CACI) Brings Tom Kirkland Back To Lead Electronic Warfare

Tom Kirkland has rejoined CACI International (NYSE:CACI) as Executive Vice President of Electronic Warfare. He will lead the company’s electronic warfare business, drawing on prior roles at CACI and L3Harris Technologies. The appointment marks a leadership change in CACI’s defense technology operations and its electronic warfare focus. The appointment of Kirkland comes as CACI International continues to compete in defense technology and services, including electronic warfare capabilities...
NasdaqGS:NWBI
NasdaqGS:NWBIBanks

Northwest Bancshares (NWBI) Appoints New CIO After Quarterly Earnings Beat

Northwest Bancshares (NasdaqGS:NWBI) reported quarterly earnings that surpassed market expectations in its latest results. The company highlighted stronger operating metrics as part of this earnings update. Northwest Bancshares announced the appointment of Chad Ballard as its new Chief Information Officer. The CIO transition is intended to support the company’s technology systems and digital capabilities. Northwest Bancshares, the holding company for Northwest Bank, operates as a regional...
NasdaqGS:ANDE
NasdaqGS:ANDEConsumer Retailing

3 Consumer Staples Stocks With Pricing Power As Food Inflation Stays High

Inflation has eased slightly to 32.11%, but with food prices still running at 35.45% and housing and utilities up 45.14%, your everyday budget may feel as tight as ever. These pressures do not hit all companies in the same way. Some food and beverage stocks can pass higher costs through to shoppers, while others may see demand soften as households adjust spending. This article looks at 3 stocks from our Consumer Staples screener that appear positively exposed to this mix of stubborn food...
NasdaqGS:PLAB
NasdaqGS:PLABSemiconductor

Photronics (PLAB) Stock Looks Stretched On Cash Flow But Reasonable On Earnings

After a strong 141.3% share price return over the past five years, Photronics now sits in a valuation tug of war, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to a premium while market multiples suggest the stock screens as undervalued. Photronics has returned 141.3% over five years, which puts extra focus on whether the current price still offers a reasonable margin for new capital. Recent weakness in the integrated circuit photomask business and uncertainty around...
NYSE:WHD
NYSE:WHDEnergy Services

3 Energy Stocks Investors Are Watching As Oil Prices React To Supply Fears

Energy stocks are in the spotlight as the Federal Reserve hints at a pause in rate hikes, big banks report earnings ahead of analyst expectations, and oil prices react to rising geopolitical tensions. That mix has pushed questions about energy supply and market stability back to the forefront. For investors who see opportunity or prefer to stay cautious, understanding which stocks are most exposed to this news can be useful. This article breaks down 3 large, established energy stocks from our...
NasdaqGS:FWON.K
NasdaqGS:FWON.KEntertainment

Is Formula One Group (FWON.K) Below Fair Value After Russell Index Removals?

Index removals put Formula One Group in focus Formula One Group (FWON.K) has been dropped from several Russell growth and midcap benchmark indexes, a shift that can prompt forced rebalancing by index-tracking funds and recalibrate how some investors view the stock. See our latest analysis for Formula One Group. Despite being removed from several Russell growth and midcap indexes, Formula One Group’s recent trading has been firm. The 7 day share price return is 6.87% and the 30 day share price...
NYSE:NFG
NYSE:NFGGas Utilities

National Fuel Gas (NFG) Stock Still Looks Below Fair Value Despite 78% 5 Year Return

National Fuel Gas stock has delivered a strong 78.0% total return over the past 5 years, yet the current valuation checks paint a more mixed picture, with some indicators pointing to an undervalued multiple and others suggesting investors should be more cautious. Recent operational moves such as the agreement to use electric fracturing technology and the planned expansion of regulated utility assets sit against this backdrop of solid long term returns and a mid range valuation score. Over...
NYSE:WMB
NYSE:WMBOil and Gas

Williams Companies (WMB) Eyes $5.5 Billion Momentum Midstream Deal

Williams Companies (NYSE:WMB) is in advanced talks to acquire Momentum Midstream for about US$5.5b. The potential deal would be one of the largest acquisitions in Williams Companies’ history. The transaction would expand Williams’ pipeline footprint into key U.S. LNG export corridors. The discussions center on Momentum Midstream’s natural gas gathering and pipeline assets that connect to Gulf Coast export markets. Williams Companies is a large U.S. natural gas infrastructure company with a...
NYSE:MSI
NYSE:MSICommunications

Motorola Solutions (MSI) Expands 911 AI On Undervalued Narrative Still In Focus

Why Motorola Solutions’ latest 911 AI upgrades matter for stock watchers Motorola Solutions (MSI) has put its Assist AI agents at the center of recent product news, adding real-time 911 call translation, live audio streaming and tighter links between dispatchers, field units and operations centers. See our latest analysis for Motorola Solutions. Motorola Solutions’ latest Assist AI rollout and the extension of Denmark’s SINE emergency network arrive as momentum has been mixed. A 7 day share...
NYSE:RF
NYSE:RFBanks

Regions Financial (RF) Stock May Be 49% Undervalued Despite Capital Markets Deal

Regions Financial has almost doubled shareholders' money over the past five years, and with the Excess Returns intrinsic value estimate indicating the stock may trade at a sizeable discount to that estimate, the key issue now is whether the recent share price still understates the underlying business or has already priced in much of that progress. Regions Financial has returned 96.0% over the last 5 years, which puts current valuation in the spotlight after such a strong stretch for long...
NasdaqGM:QNT
NasdaqGM:QNTIT

Quantinuum (QNT) Draws Fresh Analyst Support, Is The Valuation Gap A Real Opportunity?

Quantinuum (QNT) has been in focus after its post-IPO quiet period expired, as multiple Wall Street firms initiated coverage with positive ratings and highlighted its position in quantum computing and its commercial opportunities. See our latest analysis for Quantinuum. Quantinuum’s short-term share price return has been mixed, with the stock falling 4.91% over the last day, rising 4.02% over the past week, and gaining 23.48% year to date. This suggests that momentum has been building around...
NYSE:F
NYSE:FAuto

Ford Stock And Other Auto Shares Tied To Quality And Cost Cuts

Ford’s recent recognition as the top mass market brand in J.D. Power’s initial quality ranking has put a fresh spotlight on product execution, cost discipline, and management follow through. With Ford cutting warranty and materials expenses by US$1.5 billion in 2025 and targeting more savings in 2026, many investors are asking which large U.S. auto manufacturers might be most affected by this focus on quality and efficiency driven news. This article breaks down 3 stocks from our U.S. Auto...
NasdaqGS:TXG
NasdaqGS:TXGLife Sciences

10x Genomics (TXG) Leaves Russell Value Indexes, Is The Rally Already Priced In?

Index removals put 10x Genomics in focus for valuation minded investors 10x Genomics (TXG) was removed from several Russell value benchmarks on 27 June 2026, a shift that can influence trading as index tracking funds rebalance and active investors reassess the stock. For you, the key question is whether these index changes simply alter who holds 10x Genomics stock or whether they also change how the market views the company at its recent price levels. See our latest analysis for 10x...
NYSE:GMED
NYSE:GMEDMedical Equipment

Globus Medical (GMED) Secures FDA Clearances As Revenue And R And D Stay Strong

Globus Medical (NYSE:GMED) reports robust revenue growth supported by continued spending on research and development. The company secures new FDA clearances that expand its spine and orthopedic surgery product offering. Recent developments position Globus Medical as a higher growth, innovation driven investment profile compared with Medtronic. Globus Medical, a spine and orthopedics technology company, sits at the center of several long running trends in surgical care, including demand for...
NasdaqGS:CHRW
NasdaqGS:CHRWLogistics

C.H. Robinson Worldwide (CHRW) Stock Looks Rich On Earnings While Returns Stay Strong

C.H. Robinson Worldwide stock has delivered strong 5 year gains, yet its current valuation checks lean expensive, so investors are weighing sustained optimism against what the numbers say about today’s price. Over the past 5 years, C.H. Robinson Worldwide has returned 128.5%, which puts extra focus on whether the recent strength is already reflected in the share price. The acquisition of DeSpir Logistics for US$75.0m can support long term growth in higher value, security focused freight...
NasdaqGS:CDW
NasdaqGS:CDWElectronic

ResMed Stock And 2 Blue Chip Picks Retail Investors May Be Missing

Record highs in the Dow and S&P 500, a powerful chip stock rally, a stronger dollar and softer oil prices are reshaping where risk and opportunity may sit in large caps right now. To help make sense of it, this article focuses on three large cap blue chip stocks from our screener that appear especially exposed to these developments. These stocks may be affected in ways that could be either helpful or challenging, depending on your expectations and time frame. Each stock is backed by sizeable...
NasdaqGS:FIBK
NasdaqGS:FIBKBanks

Is First Interstate BancSystem (FIBK) Still Undervalued After Insider Selling?

First Interstate BancSystem has delivered a 103.8% return over the past three years, and both the intrinsic value estimate from the Excess Returns model and the earnings multiples currently point to the stock trading at a discount to their fair value read, even though the broader valuation checks are more mixed. A 103.8% three year return sets a high bar, so any perceived discount now matters for investors who care about both price and durability of that rerating. Insider selling and recent...
NYSE:PIPR
NYSE:PIPRCapital Markets

Piper Sandler (PIPR) Appoints John D’Amico To Expand Restructuring Leadership

Piper Sandler Companies (NYSE:PIPR) has appointed John D’Amico as a managing director in its restructuring group. D’Amico will focus on complex corporate restructurings and special situations within the firm’s advisory platform. The appointment expands the company’s leadership bench in an area that can be important during more uncertain economic periods. Piper Sandler enters this leadership change with its shares at $71.09 and a mixed recent track record, with the stock down 8.5% over the...
NasdaqGS:STRL
NasdaqGS:STRLConstruction

Sterling Infrastructure (STRL) Stock May Be Overvalued On Cash Flow Yet Undervalued On Earnings

Sterling Infrastructure has delivered a very large 5 year return for shareholders, yet the valuation signals are pulling in different directions, with the Discounted Cash Flow (DCF) intrinsic value estimate implying the stock trades at a premium while earnings based multiples still suggest it screens as undervalued. The stock has returned about 31x over 5 years, which puts extra focus on whether the current price still leaves a margin of safety. Growth expectations around the E...
NYSE:FLO
NYSE:FLOFood

Flowers Foods (FLO) Is Up 13.6% After Russell Index Shift to Small-Cap Benchmarks - What's Changed

On 27 June 2026, Flowers Foods was removed from several Russell 1000 and Midcap indices and simultaneously added to the Russell 2000, Russell 2000 Value, and Russell 2000 Defensive indices as part of Russell’s latest index rebalancing. This shift moves Flowers Foods out of large- and mid-cap benchmarks into the small-cap universe, potentially altering which institutional investors and index-tracking funds hold the stock and how they trade it. We’ll now examine how Flowers Foods’ move from...
NasdaqGS:INTA
NasdaqGS:INTASoftware

3 Stocks Estimated To Be Trading Below Their True Value In July 2026

Over the last 7 days, the United States market has risen by 1.4%, contributing to a robust annual climb of 19%, with earnings forecasted to grow by 19% annually. In this environment, identifying stocks that are potentially trading below their true value can offer investors opportunities for growth as they align with the market's upward trajectory and anticipated earnings expansion.
NYSE:WDH
NYSE:WDHInsurance

Spotlight On Aldeyra Therapeutics And 2 Other Prominent Penny Stocks

Over the last 7 days, the United States market has risen by 1.4%, contributing to a 19% increase over the past year, with earnings expected to grow by 19% annually in the coming years. While the term 'penny stock' might seem outdated, it remains relevant as these smaller or newer companies can offer significant opportunities when backed by solid financials. In this article, we'll explore three penny stocks that demonstrate both balance sheet strength and potential for substantial returns,...
NYSE:ORI
NYSE:ORIInsurance

Dividend Stocks for Lower Volatility as Rate Cut Hopes Lift Insurance Shares

Weaker U.S. jobs data has taken some heat out of rate hike fears, lifted gold and reminded investors that policy signals can swing sentiment quickly. For dividend investors, that mix of softer growth signals, sticky inflation risks and another leg up in safe haven demand is a cue to stress test income holdings. This article looks at how that backdrop connects to a hand picked Dividend Stocks screener, focusing on three stocks that stand out for their mix of size, dividend profile and lower...
NasdaqGM:MNKD
NasdaqGM:MNKDBiotechs

MannKind (MNKD) Wins Breakthrough T1D Grant, Is The Stock Still 11% Undervalued?

What the Breakthrough T1D grant means for MannKind The new Breakthrough T1D grant for MannKind (MNKD) and its INHALE-1 study puts Afrezza’s pediatric program in focus, coming shortly after FDA approval for children aged 6 and older. For you as an investor, the grant does two things at once. It validates Afrezza as a research priority within the type 1 diabetes community, and it helps support clinical work that MannKind would otherwise need to fund on its own. The INHALE-1 trial is centered on...